[Metabolic syndrome in schizophrenia].
The metabolic syndrome (MetS) is a serious risk factor for cardiovascular disease and type 2 diabetes, both of which are highly prevalent in patients with schizophrenia. Unhealthy lifestyle and antipsychotic medication are well known causes of MetS. Pharmacological as well as non-pharmacological interventions, including cognitive behavioural therapy, physical exercise and diet, seem to be effective in reducing MetS. Systematic screening and early intervention of MetS in patients with schizophrenia would be beneficial in reducing the risk of somatic disease and early death.
Center for Psykiatrisk Forskning, Århus Universitetshospital, Risskov, 8240 Risskov, Denmark. lene.nyboe@ps.rm.dk
Lene
L
Nyboe
Poul
P
Videbech
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects; D015928:Cognitive Behavioral Therapy; D015444:Exercise; D005247:Feeding Behavior; D006801:Humans; D008019:Life Style; D024821:Metabolic Syndrome / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy; D012307:Risk Factors; D012559:Schizophrenia / Q000150:complications* / Q000188:drug therapy; D012893:Sleep Wake Disorders / Q000150:complications; D013315:Stress, Psychological / Q000150:complications; D015430:Weight Gain / Q000187:drug effects
D014150:Antipsychotic Agents